A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO EVALUATE ENFORTUMAB VEDOTIN IN COMBINATION WITH PEMBROLIZUMAB IN ADULT PARTICIPANTS WITH MUSCLE-INVASIVE BLADDER CANCER WHO ARE INELIGIBLE FOR OR HAVE ELECTED NOT TO UNDERGO CYSTECTOMY
Status: Recruiting
Location: See all (29) locations...
Intervention Type: Drug, Radiation
Study Type: Interventional
Study Phase: Phase 3
SUMMARY
This study is being done to see how well two drugs (enfortumab vedotin and pembrolizumab) work together as a bladder preservation approach to treat patients with muscle invasive bladder cancer. The study will compare these drugs to concurrent chemoradiotherapy that is usually used to treat this cancer (standard of care). The study will enroll patients with muscle-invasive bladder cancer (MIBC) who have cancer that has not spread outside the bladder.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Has histologically confirmed initial diagnosis of muscle-invasive bladder cancer (MIBC) with predominant urothelial histology staged cT2-T4aN0M0
• Tissue comprising muscle-invasive urothelial cancer must be submitted for clinical staging at baseline
• Eligible for and agree to receive chemoradiotherapy and one of the protocol-specified radiosensitizing chemotherapy regimens
• Fit for systemic therapy and elect bladder preservation, including participants who are ineligible for or have elected not to undergo cystectomy
• Has Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2
Locations
United States
Arkansas
Arkansas Urology
RECRUITING
Little Rock
California
Samsun Clinic - Ridley-Tree Cancer Center
RECRUITING
Santa Barbara
Colorado
Rocky Mountain Cancer Center
RECRUITING
Aurora
Delaware
Medical Oncology Hematology Consultants
RECRUITING
Newark
Illinois
Hope and Healing Clinical Research LLC
RECRUITING
Hinsdale
Hope and Healing Clinical Research LLC
RECRUITING
New Lenox
Illinois Cancer Specialists
RECRUITING
Niles
Indiana
Fort Wayne Medical Oncology and Hematology
RECRUITING
Fort Wayne
Michigan
Comprehensive Urology
RECRUITING
Royal Oak
Missouri
Missouri Cancer Associates
RECRUITING
Columbia
Siteman Cancer Center
RECRUITING
St Louis
Nevada
Comprehensive Cancer Centers of Nevada - Southwest
RECRUITING
Las Vegas
New York
Icahn School of Medicine at Mount Sinai
RECRUITING
New York
Ohio
Oncology Hematology Care Clinical Trials, LLC
RECRUITING
Fairfield
Oregon
Williamette Valley Cancer Institute and Research Center
RECRUITING
Eugene
Compass Oncology - West
RECRUITING
Tigard
Tennessee
SCRI Oncology Partners
RECRUITING
Nashville
Texas
Texas Oncology
RECRUITING
Austin
Texas Oncology - Northeast Texas
RECRUITING
Tyler
Virginia
University of Virginia Comprehensive Cancer Center